If You Had Invested $100 in NuScale Power 1 Year Ago, Here's How Much You Would Have Today

NuScale Power, a small-modular-reactor specialist, experienced a sharp re-rating: shares plunged 46% over the past three months and are down 29% year-over-year as of Nov. 21, versus the S&P 500's +11.4% over the same period. A late-May surge followed President Trump’s executive orders to accelerate nuclear energy, but recent weakness and investor pullback have driven a hypothetical $100 position a year ago to approximately $70.90 today; management has not reported adverse developments, though rising volatility suggests risk-averse investors may prefer sector ETFs over company-specific exposure.

Analysis

Market structure: The near-term winners are balance-sheeted nuclear owners and supply-chain names (Cameco CCJ, BWXT BWXT) plus uranium ETF URA as risk-off flows rehome into fungible exposures; clear losers are small, single-project developers that face higher funding costs and less pricing power. Capital reallocation favors scalable OEMs and utilities able to underwrite long-term offtakes; expect M&A chatter and higher bid premia for firms with turnkey delivery in 6–24 months.

Risk assessment: Tail risks include a regulatory pause or NRC-design delay, a major prototype failure, or a forced equity raise that dilutes existing holders by 20–40%; these have multi-quarter to multi-year impact. Near-term (days–weeks) volatility will be headline-driven around DOE/NRC announcements; medium-term (3–12 months) risks stem from supply-chain bottlenecks and rising EPC costs; structural upside requires confirmed long-term PPAs or loan guarantees.

Trade implications: Favor long exposure to uranium miners/ETF (CCJ, URA) and contracts manufacturers (BWXT) while using options to hedge idiosyncratic equity risk in SMR (NuScale). Implement short-equity or put-spread strategies on SMR to monetize rich implied vol; rotate 1–3% portfolio weight from small-cap SMR exposure into suppliers and commodity plays over 30–90 days, layering on catalyst dates.

Contrarian angles: Consensus underprices policy durability of baseload low-carbon demand—if one major DOE/NRC milestone is achieved, expect a sharp re-rating (50%+ move) within 6–18 months for credible developers. However, investor attention and financing availability may take 12–36 months to normalize; asymmetric option structures or staged equity can capture upside while limiting dilution/black-swan downside.

Key Decisions for Investors

• Establish a 2–3% net long position in CCJ (Cameco) and a 1–2% position in URA to gain uranium exposure; target +30–50% upside within 6–18 months if spot U3O8 rises 20%; hard stop-loss at -20%.
• Reduce direct SMR (NuScale) equity exposure to ≤0–1% of risk budget and hedge remaining exposure by buying a 3–6 month 15–25% OTM put spread (cost-limited) sized to cover 50–75% of existing notional; close hedge if SMR implied volatility drops >25% or NRC/DOE award announced.
• Sell short-dated call spreads on SMR when 30-day implied vol >40% (e.g., sell 30–60 day 10% OTM call, buy 20% OTM call) to collect premium with defined risk; cap allocation to <0.5% of portfolio and roll or close on major regulatory headlines.
• Buy a small, asymmetric long (0.5–1% portfolio) via Jan 2027 LEAP calls on SMR ~10–20% OTM as a staged, contrarian upside play; commit additional capital only upon defined catalysts (NRC design approval or DOE loan guarantee within 12 months).
• Monitor the NRC docket, DOE loan-guarantee pipeline, and announced PPAs over the next 90 days; if any of these occur, reallocate up to +2% from uranium miners/ETF into SMR equities within 5 trading days of confirmation.